FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...
Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") (TSXV: MTA) (NYSE American: MTA) announces its operating and financial results for the three and nine months ended September 30, 2025. For ...
DPM Metals Inc. (ARBN: 689370894) ("DPM" or the "Company") announced its operating and financial results for the third quarter and first nine months ended September 30, 2025. Highlights (Unless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback